Curative Biotechnology, Inc. (CUBT)
CUBT Stock Price Chart
Explore Curative Biotechnology, Inc. interactive price chart. Choose custom timeframes to analyze CUBT price movements and trends.
CUBT Company Profile
Discover essential business fundamentals and corporate details for Curative Biotechnology, Inc. (CUBT) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
30 Mar 1998
Employees
4.00
Website
https://curativebiotech.comCEO
I. Richard Garr
Description
Curative Biotechnology, Inc. operates as a development-stage biomedical company. The company develops pipeline focusing on therapeutic areas, such as infectious diseases, oncology, and degenerative eye disease. Its pipeline candidates include IMT504, a novel immune therapy to treat rabies and an adjuvant for vaccines; CUBT906, a fully humanized CD56 monoclonal antibody carrying a pyrrolobenzodiazepine dimer directly to the tumor site to kill the tumor by inhibiting tumor growth and migration of the tumor; and Metformin Reformulation for the treatment of degenerative eye disease. The company has a licensing and co-development agreement with Mid-Atlantic BioTherapeutics, Inc. to develop IMT504 to treat late-stage rabies and COVID-19 vaccine. The company was formerly known as Connectyx Technologies Holdings Group, Inc. and changed its name to Curative Biotechnology, Inc. in November 2020. Curative Biotechnology, Inc. was founded in 1995 and is headquartered in Boca Raton, Florida.
CUBT Financial Timeline
Browse a chronological timeline of Curative Biotechnology, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 14 Aug 2025
Earnings released on 11 Aug 2024
EPS came in at -$0.00 .
Earnings released on 15 May 2024
EPS came in at -$0.00 .
Earnings released on 28 Mar 2024
EPS came in at -$0.00 .
Earnings released on 1 Jan 2024
EPS came in at -$0.00 .
Earnings released on 14 Aug 2023
EPS came in at -$0.00 .
Earnings released on 19 May 2023
EPS came in at -$0.00 .
Earnings released on 31 Dec 2022
EPS came in at -$0.00 .
Stock split effective on 2 Dec 2022
Shares were split 1 : 400 , changing the number of shares outstanding and the price per share accordingly.
Stock split effective on 14 Oct 2022
Shares were split 1 : 400 , changing the number of shares outstanding and the price per share accordingly.
Stock split effective on 3 Oct 2022
Shares were split 1 : 400 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 30 Sept 2022
EPS came in at -$0.00 .
Earnings released on 30 Jun 2022
EPS came in at -$0.38 .
Earnings released on 31 Mar 2022
EPS came in at -$0.00 .
Earnings released on 31 Dec 2021
EPS came in at -$0.00 .
Earnings released on 30 Sept 2021
EPS came in at -$0.30 .
Earnings released on 30 Jun 2021
EPS came in at -$0.77 .
Earnings released on 25 May 2021
EPS came in at -$0.20 .
CUBT Stock Performance
Access detailed CUBT performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.